G417V (p.Gly417Val) variant of SPAST (Spastin)

G417V (p.Gly417Val) in SPAST (Spastin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Hereditary spastic paraplegia 4; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes published literature and structural context.

G417V (p.Gly417Val) variant details